‘petergsazitsix| ia 29,0000 10H) Korean J Orient. int. Med. 20002001215-217 SLO] BORO] OAS BBPRAY BR ovale, wale ‘MapCHtt POLBICHAY maT DA, BIR PIOIA BIA ‘The Clinical Study of Bokryungbosim-tang on the Cough ‘Cheon-Su Park, Si-Hyeong Lee Division of Respiratiry system, Deparment of Intemal Medicine, Clee of Orensl Metiine, Workwang University tfc To sbore eat Blandi ar nb ah opts edie Skyros arg Ceical observation was cough who. 5 cas0(16.60%) ‘Conctuslons: ‘Ray Word Boteyungbositang, Cough merical rc. ‘Rleuis: The efecto treated by Bokryungbosen ang is that excolort was 19 caso(63.9%), good 8 case(10%), far 8 caso(10%) and post These resus inccate thatthe fect of Bokeyungboskn-ang onthe cough is excelent. Lm Woks Be BRS ASsIo] PH Fao] Uo} Mike PMS] es] Ute} So] det Be 37] BE 3 tht RMS] Detee age] Of, Ua RK) MEMOS A7\5| ARS RBH RAS S42 EGwH sole}. RBA SLL E WBRS} RUSK Ato] 1 OS RHONA FUR HHS) & So} Msen 2 MRSS RA OT ROK, REX MA! et ME, BOL BLS GL] SET ‘Bit, REA) Bie, AM HK C2, RES BY) F ofp} BF Ube} Aa Sei we HAS) AiReod ah RESIS Sep. Wa SARE REL, KT TCRE, HUE, Hii, HRS FS] Mi RES Bo] GBA HERICP Woks| eS BLT We AE ROS WRT MESO] YE} HIT, WS ARRBLE Mio] Se] Ko] el 2o)D) WAS ARABS S BRIE Hi ‘55121 PriBe] sto] BER. 2 ABN QoS RSS Ozh FREDO SR, 5, WA, AR ES) SIZE Biol RAR] Bekshe 23h Pawar & Rnb) eset Fett BS o| Ais Meso] Behe oe Rts lop. Ze oa (kaa a See Te, BA ON ROG FAN: 08858-2106, eal lb reakang ac) NO ERE ORME HAM a4 ad Sa AFH PAVE Wade RMS AR HER) =H ol AS ABA ALS Hiwbihel Aeslolatch. SEIS AOE, BE, J, 28, A, OE A, EE A, PH, Bt i, FR AAR, UR AR wR. slo} AG. HHO. Vo} TURE TERE 9 ASR oa EHS OE $5) woes Leste] ae HORS Qzlol Wale whole, ae 1.88 De 1) BR 199944 14 191 Fe 19993 128 31277) BABB EE SEL bet Ba T+ OTS AER214 acto! nol olay aseHS a Table 1. Sex and age distribution Table 2. Chief complain ie BF Esa tf 1) ae FC oMtelay 7 2 9 2 werk 7 4UI7 51-60 4 4 8 26.66 ‘ts 3 17.66 31-40 2 2 4 1333 2 me $F mum 11-20 1 1 2 6.66 . 71-80 1 1 2 6.66 Prt 588 ‘41-50 0 1 1 333 a 1 ‘588 61-70 0 1 1 33 BHD 5.88 att 5 5 30 100 RSV] BK AU + PERE Sees|124 WaRe tttee she SH 098 Hoe Ht. 2) ik PRMES Fol $ Asp slg AFUE AAINA. Hat HA glo} AE Bt] USES FZ so} 27] HERO SOME MAE BFE EK 2 Waa Somvidel BFE BH, seo] aay} Ge BE AO, BA, 2 BSS BLS TART. RRL WS Polat 71Eb9] WRIA Hh Fre) ob ais. RS) FRE TR AM] ARE 71ELE Hol Bikol meh pms 2. Bat 1) tS SERRA 8308 S 717} 1SHE SOB Abe Sz SO*AT. AY EES Be 10M 01847} 94ZG3%)Z 7HF BSD HES SORE 80K 26.66%) AL} BOH7E 49K33.33%), 2ONTE 3 LOK), LORS TOKE 22} 204 (6.66%), 40ft3} GOHR7E 42} 161 G.33%)2 Yebte(Table 1). 2) SRE RL BH} 16GKS3.33%), HH, DRA AF 14GK46.66%) B27) HK 9 ARS ANG EOE QL BF7b THMAL.7%), HAAM3B TO] SHA BF 39017.64%), FRR pes MINAS] 22} 28K(11.76%), FF tb, MBB, BHHHiel Zh 15.88%) S ebtCH Table 2), 3) Fea HAM slol= 1744 ose AF 176(73.91%), 2AD ola} B + 20M(8.69%), 34-0] 87} 161 (4.34%), 3H I BH3H (13.04%) YEPATH aBI7t 23009) a B47 WAS Ags] BEE ALE ARAYA Table 3). 4) afierane 59 o}8}2) B4-7k 105K33.33%), 6 2 dB 108 sel Bort 134 (43.33%), 11 14 208 olatel 4B 47 SHK16.66%), 212 ©]4} 309) ©] Bal B+ 28H6.66%)= 108 ola}e) BIN 16.66%%. AHR ars (Table 4). ‘Table 3. Duration distribusion a TA ot 7 B91 2A ola 2 8.69 37 ol 8 1 434 aad 313.08 Table 4, Treatment duration ae 19 ola 4 18.18 6Y~109 o]3} 50 119~209 o]@} 5 2272 See wt BE 19 RE 3 ‘imi 3 Blt, 5 aay 30 HAK%) 6333 10 10 16.66 100 Table 6. Relation of duration and cure rate semen & 5a oe 10 od-10Vl# 13, 119-209¢)3 5 21-309 1} 2 30 S84) 3333 4333 16.66 6.66 1005) SEO] AU HH (50%]45} 7hAd)7t 196 (63.33%), AHSO%P] RE] 7HA4)7} 3 (10%), SURICAE He) 361 (10%), BAL7t 59M(16.66%)= YEbst (Table 5). 6) RR HF AHS 71S OS sho} Boh 6 YAM 109 olahel B47} 116 (50%)Z 7 BT 11244} 208 0} 8 7b 58K22.72%), 5 lst} 465) (18.18%), 21Ge14] 30% °]8}7t 264 (0.09%) Sie} Table 6). I dele 1472 HSE Bsa Beas ANE Bola BB EE IAA BE. 7) aA AS Ae ge HF BF] ajaqoe Mae. Solo} VA =Hs} 0] 3} 87) 289 FF08 AA ABH IE YW de] Joxn Sid AE] & VALS MISS ARE B77 Bt. WVSAS Vel 71a MMe] 3 Folle Me Ta7laolet sa 37 ogo) a aa7iaole} teh. aa ay ay ee 7h £8 Ale WIE & FF, VF, EMBs] whole At aaa Aly W714 9 PE FE Ale HAold. Fel $9 7H BE dy7lasl 4d Ale 718] 24, FFSHEZ, MASS 4.04 7119 Ee 718) BS old. = 7142 oad aba aA Ze HEY aaa, ae Fee #a EE Bq ely 9 ME £7 1d. US Is Bes ES 714lo) FAM F OP} 6-87 AGH FE IG, Azle LR B49) Virsy ed 22 Ut EKO oy Ad aes = 497 a. OE 2] 7H EM Aeole, a} 49] Saal Boley] Behe sys} SEREELS oleshe Zo] SA. KE BE 48-724 Ze|o} HS We 3, RE, 24), AA), VES, 714, 4, SEF HME] oL¥o] 7 a Th. 19) ERS 24UA4 AD Ga ZL old Virus#¥/7} 7F #29] HS GA AD setet= OSve]e seit A) Beth 7 S-6¥ele Fo}a|ajat 1FQe] AWS AF) Sa E SCSI) 71218, AG, TIERS) BR UA a7/71 hd B47} sich RELKE ME) KLiGol Ge} tec s rd. Ee wee BAM} WpRMOS Uech & ES FAK S Wah, EK, SS eH Sol] AE APS LH SsHs det. qe 2 Sut HERS Told AF = BH HS AAG F Uh. PAZ 19] F2 Bepashe SH RS) HUE, ELAS) BRIE, TH OWS HE, ES {EMRE BLO] 2 20Gb. AHEM) ERIE BUGS SATS ARS) RUM, HDUY, AIRS) HE, M9) Mn RSS PN) A RE Seatol S| WEA BEI} REE St Sat ta Hz49 S80] we. E Se AERA SB “RAS mel Step. Wak HARB oy ERA A) SHARES - BRE RGE)” ANAS Mel Bete 71Fo] WEA) Bart AUF a ae AS ARE 2 BP EE Ko] Wa 2eI7} KL0| MS He] Gat Ael7} geF eb ont wales 215 EERO ROL TS MS Fl WE] Beka @ ale) olele a 2 HSLO0) ROS WS eS BS A 1 oy 3 AURE PHEW Ml Asie} lob] @ 2elch. 2 7HE SI] AVE RE BE TS BON. Bee E oleh nk & wloleh aban asic. DKS) WS BARRE] PRE *F SOU BRED) BR} 122] 16 Be HE EHO] TE ole] BE” 4 2 RS Opskeh. Wake] BRS. 382 "mko] BES. Til 744) SOU, SHE HES) &, SUE PAB Bo} fel wma} Awe BR, iD, te, OOS ARS oe HA BOHRA 9) FHS cet BSR Uso] aS E771 312 tel LEAS Ail PNR BAbaha seh. RAMEE Ret BR SEG AS Hk ILL Het BAO}, AS Fz Honbitol AESIAe. ‘PeeEH) Ros Uv Gere, BS, 1, PURE Dirigo es Him BUF AB, CRF, HR, A, Aa = BETES ako AMIR EA RS Ee ho] eansp Mak, BR, 11H, ake. i. 2A ii MADD BRE FleUT ORR ao) ASHES AEMBILR HEALD ‘BRS ATS aelo} waste Rake BRUT MMS Wee] HS SS HA) >) BUA BAS fics eS ne. RERIBS RF SS MORE TY dato! Mie SHE ty] ge 1, LBA HB Zhe. BES A iF, SEEMS] BOE feo] shoo}, bee) BLsenhe] AB) sheh. AIG 2 0a SRK DAES) Alc.216 aaecsBo! wot ols RI 9 SHAKE GRR, (e8ULM, BADE > sate] 17] Al, Makitiseel| 9} a era Me] SH RE AS A FE RAG. F BAH ii sol BAAN AAS] WBA, Heist] Rens sults) Sha7t Tks AS] HK So] ole RT BE 52] BAe] B3 WH, $6, Se Waite} Fat Ae SES Yc. ibe Mim, BE) Riko] slo EM IO BS AU ee eS) MARFA] FSR el. = ble OK, HFRS tol 8 Se Mth] PAS Nol ole AS 9) bit BORE Sch. CHAE Hi, ses HE Ham HS AT Hist, Watt] 9] His) APRS AAG fh we Be SHA ZAG Sep. HS] OZ Bo Bat Bet Ope) PBI ATES 9 eh BA A HS MBA SI 1G. 165) SER THE Be Aw 307 & PAT SAS SO%AD AHe 15 AZ. 50% SiC. ‘Fi BAS BA 1044 o]8}7} Doz (33%)2 7H WIT HESS SORE BPA (26.66%) A 2} 3071 46 (33.33%), 20K} 36K10%), 10ft 3} ‘TOR 232} 2046.66%), 40ft3} OOF FEA} 1AG33%)Z VEN. EMREA ola AA A471 166 (53.33%), BK, PHI BF 1404 (46.66%) AO] BH, ERS ASS EEA LRA 3471 78 (41.17%), MANGE TIS) ZF 364 (17.64%), PAREREST DeS HBA ©} 22} 26K 11.76%), FFE, MBB, BA io] 2} 19KS. 88%) Yebsteh. KA NOE MAK] Po] Beka RH BLS AT. AME ole Lia lta AF 179K73.91%), 27 oli! B + 2M(8.69%), 3719 o]8b7} 16) (4.34%), 34@ oltel 24 36 (13.04%) ERAT. seBi7t 23612) a Ba7t WAS Bes] Bee APE AMAA. IAW olstel A+ 7t7PS BRO AA EMS 72) olgttt. HGRA! Lol] Sq] ola}el 24 7} 108K33.33%), 6Y ol 104) 013} 1 B47} 136K43.33%), 112 |b 208 ols}! 3471 504 16.66%), 21 © ols 308 lie) BF 28K6.66%) 2108 o8}el 8471 76.66%2 AF Hapa. SE sh] ABE Slo ISO V2] AAA} 1981(63.33%), BAF (50%H] 32} 7A)7t 36K 10%), A CaF Bshe] 361%), Att S61 (16.66%) Yebtt. Atel HE 2 BLS 46K ZF 104] o}3}9} oo] 2 GRAM) SF 7/7 Wespsion} 1GKE 2749] BRE Bikol F5 Volt Vel weet dae fz 5a E2] BRS FRU wire] A AAG. °] SHE RI MMT] Be] SAG. BAT) LE 9) BREE BH} ERE cl AA ERS) BGs 7H ghee BW ed. OSL So MLS SERA FA Bol AB F7t On} KAKO] We Wace AeOIAY baal B $9} ES —H HE] SAE Fo] SHEE Woke ALBA + gloelet & at. \V. 8 199944 19 191 FE} 199912 129) 31D 77] BRR IR BL) ET Ot TY PAPE IUS Ree Ba S44 Bel 2 + MERE WSI1OU Wake ios se B #% 38S WYO so] WH] oh $5 V2 AS Asie 1. HE Bee 42h 1598 lB DEBS) DA] oe 104 ols} 7} 9B33%)= 7H} BStom} SOFT 826.6%) $1. 2, EEHED slo sae B7b 1G6KS3.33%). HK, HRA 4 140) (46.66%) RL} BOR, HERS AIR EMEA CRRA 47t 761 (41.17%), HAAG C18) BF 304 (17.64%), PRES WORE NBER 2] 22} 26M(L1.76%), FF, BABE, $0] 212} 1.88%) Eb SEMI Soltis 1718 1842) BF VTHKTI.IL%), 271 Ol@el F 26M(8.69%), 3719 ol 8b7t 161 (4.34%), 34D 4A B36 (13.04%) UEC, 4. iaAERATC Slo}4} Salo] ate) 3 $7 108433.33%), 62 ©] 102) 0] el BF7t 138K43,33%), 112 ofp 20¢ ola}el 39-74 504 16.669), 21 Qo} 308) lstel 2 28K6.66%) 2 109 ola}¢i 397} 76.66%. HY e abslaiatch 5. HERR REO SoS EI (50%2] 432] 7441)7b 1941(63.33%), REXSO% |S] 7HA)7} 36(10%), ‘ORICA BS] 36K 10%), BALES A16.66%)= YEACH, S14 MBS Hates) Wi7t ExEIAG BHAA Fojsjo] yURE USO, GHA BR SB HLobMS ABU} oe] HME S| RBS AS of BS HIE = 228 Bac. V. CBM 1. WA #0, POR, A A, 1994; 277~290. 2. Jay H. Stein. MD, Interal Medicine, Boston : Lite, Brown and Company, 1943 ;320~321, 3. DeME FRAN, me: BET ‘HE i874, 1983 ; 1011. 4 OE ORR, A EE, 1990 ; 151,170. 5, ORATOR, PRPS, HE LEE ‘peeami, 1982 ; 82 10. a. 2 B. “4 15. 6. DSUAIML, SISTIONAC AR ALS = RAB, 1976; 71 eA, ERS, bie: Lier Mit 1958 ;78~79, Fre, OWE, AE UL, 1987 5 109,467~468. Fh AE RBM, Ae: & ASH FEE ,1996; 105~107,310 au. WB, S05, : ta 1977 270. HER, AR, AS le, 1984 5 201~208. 7, WP, AE s Delete, 1998 5 403~404, RAEN A ETOH MOP NG a 8H 1980; 48 EI PEE, SOR: MG ‘Bat, 1984; 131. SHO, OTR, A: TALL, +2, Mt, DRT, A ULAR, 0. 8, O1Met 84% 217 1992; 92~94,157 EF, ORR AG TREAD, 1983 5 (£8) 586.588. AK AER, NS: 2,335, EA, POONER, THE: SY ‘RMA, 1983; 128~130. AR, MBI, A: BERL #1978 91. |, 1992 5 PN, RINSE ACR, Rs BE 2, 1998; 204. PO, TOMI, NS: 1988 ; 149. FIR, BBM, dal AME, 1999 ; 8. tA, LOI, AE: KIB, 1993; 39. Mek, WME, a7 HeTEOIER ‘ARE, 1987; 78,